Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis
Selma Tuzlak, Manuel D Haschka, Anna-Maria Mokina, Thomas Ruelicke, Suzanne Cory, Verena Labi, Andreas Villunger
The FEBS Journal | WILEY | Published : 2018
Awarded by Austrian Science Fund (FWF)
Awarded by MCBO Doctoral College 'Molecular Cell Biology and Oncology'
We thank all members of the Villunger laboratory for their support and advice. Special thanks to K. Rossi, C. Soratroi and I. Gaggl for animal care and excellent technical assistance, S. Herzog for reagents and L. Fava for helpful discussion. We also thank M. Herold (WEHI) for the anti-A1 antibody and J. Borst (NKI) for the anti-BFL1 antiserum. This work was supported by grants from the Austrian Science Fund (FWF), Grant I 3271 (FOR-2036), the MCBO Doctoral College 'Molecular Cell Biology and Oncology' (W1101) and the 'Osterreichische Krebshilfe Tirol'. MDH and ST are supported by a DOC-fellowship from the Austrian Academy of Science (OAW).